TC
Alaunos Therapeutics, Inc.
TCRT · NASDAQ
$1.51 -1.95% (-$0.03)
1M -21.76%
Market Cap $3.81M
P/E Ratio -
Div. Yield -
ROE 232.60%
Piotroski F-Score Weak
1/9Valuation
14 /100
Expensive P/S 1,269.59x
P/B 5.84x
P/E N/A
Growth
0 /100
Declining Rev. growth 88.04%
Book val. growth 61.78%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 27,833.30%
Net margin 133,667.00%
Op. margin 135,267.00%
Quality
0 /100
Poor ROIC 622.39%
ROE 232.60%
ROA 264.51%
Debt
74 /100
Low Debt/Equity 0.00x
Current ratio 0.77x
Int. coverage N/A
Stability
29 /100
Unstable Beta -0.97x
Rev. volatility 104.01%
EPS volatility 38.77%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TCRT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Holger Weis
Employees
1
Headquarters
Fort Lauderdale
Evenimente viitoare
17 NOV.
Earnings
Upcoming earnings report